KPNβ1 and NKCC1 Modulators as Key Players in HCC: Possible Interventions in Cell Cycle Arrest and Apoptosis.
Hepatocellular carcinoma (HCC) remains a major challenge threatening global health. It has a high incidence with poor prognosis, and its response to current conventional therapies is not satisfactory, so we need to explore new effective therapies to address this problem. Targeted therapy represents a promising approach...